Yi Lai
160 Pujian Road
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
RAFusion: Integrating Residual Attention for Global Context-Aware 6D Pose Estimation.
Journal: Sensors (Basel, Switzerland)
Published: June 20, 2026
Molecular design and delivery of extracellular and membrane protein degradation chimeras.
Journal: Advanced drug delivery reviews
Published: February 05, 2026
Chiral and Dual Drugs Combination Reduces Tumor-Associated Neutrophils-Induced T-Cell Immunoparalysis to Treat Epithelial Ovarian Cancer.
Journal: Molecular pharmaceutics
Published: January 08, 2026
Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications.
Journal: Advanced drug delivery reviews
Published: November 26, 2025
Hypoxia-responsive paclitaxel prodrugs: linker evaluation and NIR-triggered self-amplifying photodynamic-chemotherapy nanoplatform.
Journal: Biomaterials
Published: November 24, 2025
Pose-Perceptive Convolution: Learning Geometry-Adaptive Receptive Fields for Robust 6D Pose Estimation.
Journal: Sensors (Basel, Switzerland)
Published: November 10, 2025
Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery.
Journal: Advanced drug delivery reviews
Published: October 31, 2025
A senescent tumor cell-derived nanovesicle directly primes splenic T cells to potentiate cancer radiotherapy.
Journal: Cell reports. Medicine
Published: September 24, 2025
Molecular Rotor-Based NIR-II TICTgens for Mitochondria-Targeted Pyroptosis Induction and Multi-Model Monitoring of Cancer Immunotherapy.
Journal: Angewandte Chemie (International ed. in English)
Published: April 18, 2025
A Tumor-homing nanoplatform for the co-delivery of triptolide and siRNA-A4B2 conspicuously overcomes peritoneum metastasis of ovarian cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 07, 2025
Last Updated: 09/26/2026